hrp0094p1-36 | Fat, Metabolism and Obesity A | ESPE2021

Reversal of metabolic derangement in patient with congenital generalized lipodystrophy treated with metreleptin

Aljubeh Jamal ,

Lipodystrophy syndromes are a heterogeneous cluster of complex, life-threatening, rare diseases associated with reduced levels of leptin and include Congenital Generalized Lipodystrophy (CGL). Patients are at significant risk of developing metabolic problems that include elevated triglycerides, severe insulin resistance, and impaired glycemic control, and abnormalities in multiple organs. We report a case of 16-year-old Emirati female with CGL with special focus on reversal of...

hrp0097p1-106 | GH and IGFs | ESPE2023

Growth Hormone (GH) Therapy in Children with short stature: A cross-sectional study of indication and treatment outcomes- 12-year single center experience

Al Jneibi Sara , Hammouri Marwa , Taha Fatima , Allami Zahraa , Weber Stefan , AlJubeh Jamal , Al Remeithi Sareea

Background: GH deficiency remains the main indication for GH therapy in children. GH therapy has subsequently been approved in the USA and Europe for other conditions resulting in short stature, including Turner Syndrome, being born small for gestational age with failure to attain normal growth, Prader-Willi Syndrome, chronic renal insufficiency, short stature homeobox-containing gene deficiency, and in the USA exclusively Noonan Syndrome and idiopathic short ...